Skip to content

Multicenter clinical study of nalbuphine in postoperative analgesia after laparoscopic surgery in the elderly

Multicenter clinical study of nalbuphine in postoperative analgesia after laparoscopic surgery in the elderly

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110764
Enrollment
Unknown
Registered
2025-10-20
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute postoperative pain

Interventions

Normal saline control group:An equal amount of normal saline was given before the surgical skin incision
Nalbuphine intervention group:0.1mg/kg nalbuphine injection was given before the surgical skin incision

Sponsors

Quzhou People Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for laparoscopic surgery (including appendectomy, cholecystectomy, hernia repair, hysterectomy, renal cystectomy, etc., with an estimated operation time of less than 3 hours); 2. Age: 65 to 85 years old; 3. ASA ? or ? grade; 4. BMI 18~30kg/m^2; 5. Have a clear understanding of and voluntarily participate in this research, and have the informed consent form signed by themselves or their family members.

Exclusion criteria

Exclusion criteria: 1. Patients with mental system disorders who have been taking related medications for a long time; 2. Those with obvious dysfunction of important organs before the operation, bradycardia (heart rate < 50 beats per minute), severe obstructive pulmonary disease, grade III atrioventricular block, and ASA grade III or above; 3. Those who are allergic to or have contraindications to opioid analgesics and other drugs and their components; 4. Long-term use of analgesics, previous history of alcohol addiction, and history of chronic pain.

Design outcomes

Primary

MeasureTime frame
VAS Pain score;The incidence of hypoxia and hypotension during the postoperative recovery period;

Secondary

MeasureTime frame
Anesthesia satisfaction;Postoperative cognitive dysfunction score;Ramsay sedation score 30 minutes after extubation;PACU stay time;Incidence of nausea and vomiting;The total amount of sufentanil used within 48 hours and the time of the first analgesia;Postoperative sleep quality;The incidence of postoperative dizziness and drowsiness;

Countries

China

Contacts

Public ContactXiangyu Fang

Quzhou People Hospital

fangxy999@foxmail.com+86 13957759995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026